Filed by Per-Se Technologies, Inc.
                          Pursuant to Rule 425 under the Securities Act of 1933,
                            as amended, and deemed filed pursuant to Rule 14a-12
                           under the Securities Exchange Act of 1934, as amended

                                          Subject Company: NDCHealth Corporation
                                                  Commission File No.: 001-12392

 On December 28, 2005, Per-Se Technologies, Inc. issued the following
 press release:


[PER SE TECHNOLOGIES LOGO]


                                                             PER-SE TECHNOLOGIES
                                                          1145 Sanctuary Parkway
                                                                       Suite 200
                                                       Alpharetta, Georgia 30004

                                                                    877/73PER-SE
                                                                  www.per-se.com



                                                CONTACT:
                                                Michele Howard
                                                Per-Se Technologies
                                                voice: 770/237-7827
                                                email: michele.howard@per-se.com

FOR IMMEDIATE RELEASE

            PER-SE TECHNOLOGIES ANNOUNCES ADJUSTMENT TO INCREASE CASH
               CONSIDERATION UNDER MERGER AGREEMENT WITH NDCHEALTH
            CORPORATION; TOTAL CONSIDERATION REMAINS $19.50 PER SHARE

ALPHARETTA, GA. -- DECEMBER 28, 2005 -- Per-Se Technologies, Inc. (Nasdaq: PSTI)
today announced that it has elected to exercise its right to increase the cash
portion (with a corresponding decrease to the stock portion) of the merger
consideration under the terms of its previously announced merger agreement with
NDCHealth Corporation (NYSE: NDC). As a result of this election, upon the
closing of the merger, each share of NDCHealth common stock will be converted
into the right to receive $14.05 in cash, plus a number of shares of Per-Se
common stock equal to $5.45 divided by an applicable price per share of Per-Se
common stock. Unless Per-Se makes certain issuances of common stock prior to the
closing, the applicable price per share of Per-Se common stock will be the
average of the volume weighted sales prices per share of Per-Se common stock on
the Nasdaq National Market for the 20 consecutive full trading days ending on
the third trading day prior to, but not including, the closing date of the
merger.

Each company will hold a special meeting of stockholders on January 5, 2006, to
consider matters relating to the proposed merger. The merger remains subject to
customary closing conditions, including requisite approvals by the stockholders
of both companies. The parties expect to close the proposed merger transaction
soon after the companies conduct their special meetings of stockholders and
receive the requisite stockholder approvals.




                                                             Per-Se NEWS Release
                                                                     Page 2 of 2


ABOUT PER-SE TECHNOLOGIES
Per-Se Technologies (Nasdaq: PSTI) is the leader in Connective Healthcare.
Connective Healthcare solutions from Per-Se enable physicians and hospitals to
achieve their income potential by creating an environment that streamlines and
simplifies the complex administrative burden of providing healthcare. Per-Se's
Connective Healthcare solutions help reduce administrative expenses, increase
revenue and accelerate the movement of funds to benefit providers, payers and
patients. More information is available at www.per-se.com.

                                    - more -


SAFE HARBOR STATEMENT
This press release contains statements that constitute "forward-looking
statements" within the meaning of the Securities Act of 1933 and the Securities
Exchange Act of 1934, both as amended by the Private Securities Litigation
Reform Act of 1995. These statements are based on the current expectations of
management of both companies. There are a number of risks and uncertainties that
could cause actual results to differ materially from the expectations of
management. You are encouraged to consult the filings which Per-Se makes with
the Securities and Exchange Commission for more information concerning such
risks and uncertainties. You are cautioned not to place undue reliance on these
forward-looking statements which speak only as of the date stated, or if no date
is stated, as of the date of this press release.

IMPORTANT LEGAL INFORMATION
This communication is being made in respect of the proposed merger involving
Per-Se Technologies and NDCHealth Corporation. This communication shall not
constitute an offer of any securities for sale. Per-Se has filed with the SEC a
registration statement on Form S-4 that includes a joint proxy
statement/prospectus and other relevant documents concerning the proposed
merger. Stockholders of Per-Se and NDC are urged to read the registration
statement and the joint proxy statement/prospectus, and any other relevant
documents filed with the SEC, because they contain important information. You
may obtain copies of all documents filed with the SEC regarding this
transaction, free of charge, at the SEC's website (www.sec.gov). You may also
obtain these documents, free of charge, from NDCHealth's website
(www.ndchealth.com) under the tab "Investor Relations" through the "SEC Filing"
link or from Per-Se's website (www.per-se.com) under the tab "Investors" through
the "SEC Filing" link.


                                      # # #